These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 18706774)

  • 1. Correlates of extramedical use of OxyContin versus other analgesic opioids among the US general population.
    Martins SS; Storr CL; Zhu H; Chilcoat HD
    Drug Alcohol Depend; 2009 Jan; 99(1-3):58-67. PubMed ID: 18706774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profile of dependence symptoms among extramedical opioid analgesic users.
    Martins SS; Ghandour LA; Chilcoat HD
    Addict Behav; 2007 Oct; 32(10):2003-19. PubMed ID: 17270358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002-2004.
    Cicero TJ; Inciardi JA; Muñoz A
    J Pain; 2005 Oct; 6(10):662-72. PubMed ID: 16202959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in the Nonmedical Use of OxyContin, United States, 2006 to 2013.
    Jones CM; Muhuri PK; Lurie PG
    Clin J Pain; 2017 May; 33(5):452-461. PubMed ID: 27513641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abuse of reformulated OxyContin: Updated findings from a sentinel surveillance sample of individuals assessed for substance use disorder.
    Cassidy TA; Thorley E; Black RA; DeVeaugh-Geiss A; Butler SF; Coplan P
    J Opioid Manag; 2017; 13(6):425-440. PubMed ID: 29308589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abuse-Deterrent Formulations and the Prescription Opioid Abuse Epidemic in the United States: Lessons Learned From OxyContin.
    Cicero TJ; Ellis MS
    JAMA Psychiatry; 2015 May; 72(5):424-30. PubMed ID: 25760692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding the patterns and distribution of opioid analgesic dependence symptoms using a latent empirical approach.
    Ghandour LA; Martins SS; Chilcoat HD
    Int J Methods Psychiatr Res; 2008; 17(2):89-103. PubMed ID: 18393262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential influences on initiation and persistence of extramedical prescription pain reliever use in the US population.
    Dowling K; Storr CL; Chilcoat HD
    Clin J Pain; 2006; 22(9):776-83. PubMed ID: 17057559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of nonmedical use of OxyContin and other prescription opioid pain relievers before and after the introduction of OxyContin with abuse deterrent properties.
    Cheng HG; Coplan PM
    Postgrad Med; 2018 Aug; 130(6):568-574. PubMed ID: 29978755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward primary prevention of extra-medical OxyContin® use among young people.
    Deandrea DC; Troost JP; Anthony JC
    Prev Med; 2013 Sep; 57(3):244-6. PubMed ID: 23701847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the potential impact of a reformulated version of oxycodone upon tampering, non-adherence and diversion of opioids: the National Opioid Medications Abuse Deterrence (NOMAD) study protocol.
    Degenhardt L; Larance B; Bruno R; Lintzeris N; Ali R; Farrell M
    Addiction; 2015 Feb; 110(2):226-37. PubMed ID: 25358480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-medical use of OxyContin Tablets in the United States.
    Sees KL; Di Marino ME; Ruediger NK; Sweeney CT; Shiffman S
    J Pain Palliat Care Pharmacother; 2005; 19(2):13-23. PubMed ID: 16061457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of abuse-deterrent OxyContin on prescription opioid utilization.
    Hwang CS; Chang HY; Alexander GC
    Pharmacoepidemiol Drug Saf; 2015 Feb; 24(2):197-204. PubMed ID: 25393216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Illicit use of opioids: is OxyContin a "gateway drug"?
    Grau LE; Dasgupta N; Harvey AP; Irwin K; Givens A; Kinzly ML; Heimer R
    Am J Addict; 2007; 16(3):166-73. PubMed ID: 17612819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Internet-based survey of nonmedical prescription opioid use in the United States.
    Katz N; Fernandez K; Chang A; Benoit C; Butler SF
    Clin J Pain; 2008; 24(6):528-35. PubMed ID: 18574362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescription OxyContin abuse among patients entering addiction treatment.
    Carise D; Dugosh KL; McLellan AT; Camilleri A; Woody GE; Lynch KG
    Am J Psychiatry; 2007 Nov; 164(11):1750-6. PubMed ID: 17974941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discordant reporting of nonmedical opioid use in a nationally representative sample of US high school seniors.
    Palamar JJ; Shearston JA; Cleland CM
    Am J Drug Alcohol Abuse; 2016 Sep; 42(5):530-538. PubMed ID: 27315427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing rates and characteristics of ambulance attendances related to extramedical use of pharmaceutical opioids in Victoria, Australia from 2013 to 2018.
    Nielsen S; Crossin R; Middleton M; Lam T; Wilson J; Scott D; Martin C; Smith K; Lubman D
    Addiction; 2020 Jun; 115(6):1075-1087. PubMed ID: 31742765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained reduction of diversion and abuse after introduction of an abuse deterrent formulation of extended release oxycodone.
    Severtson SG; Ellis MS; Kurtz SP; Rosenblum A; Cicero TJ; Parrino MW; Gilbert MK; Buttram ME; Dasgupta N; BucherBartelson B; Green JL; Dart RC
    Drug Alcohol Depend; 2016 Nov; 168():219-229. PubMed ID: 27716575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OxyContin® as currency: OxyContin® use and increased social capital among rural Appalachian drug users.
    Jonas AB; Young AM; Oser CB; Leukefeld CG; Havens JR
    Soc Sci Med; 2012 May; 74(10):1602-9. PubMed ID: 22465379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.